Mereo BioPharma will cut 40% of its headcount and significantly reduce expenses to support the advancements of its lead programs through the clinic, the company announced Tuesday.
https://www.pharmalive.com/wp-content/uploads/2022/09/BioSpaceexit9-2-2022.jpg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2022-10-18 08:40:472022-10-18 10:00:23Mereo BioPharma slashes headcount by 40% to save rare disease programs